Your browser doesn't support javascript.
loading
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.
Solomon, Scott D; Lowenstein, Charles J; Bhatt, Ankeet S; Peikert, Alexander; Vardeny, Orly; Kosiborod, Mikhail N; Berger, Jeffrey S; Reynolds, Harmony R; Mavromichalis, Stephanie; Barytol, Anya; Althouse, Andrew D; Luther, James F; Leifer, Eric S; Kindzelski, Andrei L; Cushman, Mary; Gong, Michelle N; Kornblith, Lucy Z; Khatri, Pooja; Kim, Keri S; Baumann Kreuziger, Lisa; Wahid, Lana; Kirwan, Bridget-Anne; Geraci, Mark W; Neal, Matthew D; Hochman, Judith S.
Afiliação
  • Solomon SD; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.S., A.S.B., A.P., A.B.).
  • Lowenstein CJ; Johns Hopkins School of Medicine, Baltimore, MD (C.J.L.).
  • Bhatt AS; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.S., A.S.B., A.P., A.B.).
  • Peikert A; Kaiser Permanente San Francisco Medical Center, CA (A.S.B.).
  • Vardeny O; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.S., A.S.B., A.P., A.B.).
  • Kosiborod MN; University of Minnesota and the Minneapolis VA Medical Center (O.V.).
  • Berger JS; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City (M.N.K.).
  • Reynolds HR; Cardiovascular Clinical Research Center, NYU Grossman School of Medicine, New York (J.S.B., H.R.R., S.M., J.S.H.).
  • Mavromichalis S; Cardiovascular Clinical Research Center, NYU Grossman School of Medicine, New York (J.S.B., H.R.R., S.M., J.S.H.).
  • Barytol A; Cardiovascular Clinical Research Center, NYU Grossman School of Medicine, New York (J.S.B., H.R.R., S.M., J.S.H.).
  • Althouse AD; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.S., A.S.B., A.P., A.B.).
  • Luther JF; University of Pittsburgh, PA (A.D.A., J.F.L., M.W.G., M.D.N.).
  • Leifer ES; University of Pittsburgh, PA (A.D.A., J.F.L., M.W.G., M.D.N.).
  • Kindzelski AL; National Heart, Lung, and Blood Institute, Bethesda, MD (E.S.L., A.L.K.).
  • Cushman M; National Heart, Lung, and Blood Institute, Bethesda, MD (E.S.L., A.L.K.).
  • Gong MN; Larner College of Medicine, University of Vermont, Burlington (M.C.).
  • Kornblith LZ; Albert Einstein College of Medicine, Bronx, NY (M.N.G.).
  • Khatri P; University of California, San Francisco (L.Z.K.).
  • Kim KS; University of Cincinnati Medical Center, OH (P.K.).
  • Baumann Kreuziger L; University of Illinois, Chicago (K.S.K.).
  • Wahid L; Versity Blood Research Institute, Milwaukee, WI (L.B.K.).
  • Kirwan BA; Duke University, Durham, NC (L.W.).
  • Geraci MW; Socar Research SA, Nyon, Switzerland (B.-A.K.).
  • Neal MD; University of Pittsburgh, PA (A.D.A., J.F.L., M.W.G., M.D.N.).
  • Hochman JS; University of Pittsburgh, PA (A.D.A., J.F.L., M.W.G., M.D.N.).
Circulation ; 148(5): 381-390, 2023 08.
Article em En | MEDLINE | ID: mdl-37356038

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article